Insider Transactions Reported by 16 Insiders of Immuneering Corp

Symbol
IMRX on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Immuneering Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BENJAMIN J. ZESKIND PRESIDENT AND CEO, Director $9,928,137 +$85,023 +0.86% 03 Feb 2026
Cormorant Asset Management, LP 10%+ Owner $8,598,961 01 Apr 2024
Peter Feinberg Director $6,947,380 +$288,747 +4.3% 12 Jan 2026
Brett Matthew Hall Chief Scientific Officer $1,720,586 +$45,118 +2.7% 03 Feb 2026
Thomas J. Schall Director $347,913 +$225,107 +183% 15 Jan 2026
Mallory Morales SVP Finance, CAO $175,935 +$1,917 +1.1% 03 Feb 2026
Leah R. Neufeld Chief People Officer $107,853 +$18,508 +21% 03 Feb 2026
Harold Eugene Brakewood Chief Business Officer $52,598 +$29,794 +131% 03 Feb 2026
Michael D. Bookman Chief Legal Officer, Secretary $33,261 +$6,966 +26% 03 Feb 2026
Biren Amin Cfo, Treasurer $23,773 12 May 2022
DIANA HAUSMAN Director $19,862 +$19,863 02 Jul 2025
LAURIE KEATING Director 01 Jan 2026
CARPENTER ROBERT J Director 13 Jun 2025
Igor Matushansky Chief Medical Officer 03 Feb 2026
ANN E. BERMAN Director 13 Jun 2025
Scott Barrett Chief Medical Officer 15 Feb 2023

Recent Insider Transactions by Companies or Individuals for Immuneering Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.